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Implantation of the fertilized egg into the maternal uterus depends on the fine balance
between inflammatory and anti-inflammatory processes. Whilst regulatory T cells (Tregs)
are reportedly involved in protection of allogeneic fetuses against rejection by the maternal
immune system, their role for pregnancy to establish, e.g., blastocyst implantation, is not
clear. By using 2-photon imaging we show that Foxp3+ cells accumulated in the mouse
uterus during the receptive phase of the estrus cycle. Seminal fluid further fostered Treg
expansion. Depletion of Tregs in two Foxp3.DTR-based models prior to pairing drastically
impaired implantation and resulted in infiltration of activated T effector cells as well as in
uterine inflammation and fibrosis in both allogeneic and syngeneic mating combinations.
Genetic deletion of the homing receptor CCR7 interfered with accumulation of Tregs in
the uterus and implantation indicating that homing of Tregs to the uterus was mediated
by CCR7. Our results demonstrate that Tregs play a critical role in embryo implantation by
preventing the development of a hostile uterine microenvironment.
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INTRODUCTION
Normal pregnancy is a physiological state during which dis-
tinct processes take place at different stages. Pregnancy begins
with the fertilization of the ovum, followed by implantation of
the blastocyst in the maternal uterus. To implant, the blastocyst
needs to adhere to the endometrium so that it can be pro-
vided with oxygen and nutrients. For these changes to occur
tissue remodeling and inflammatory processes in the uterus are
required. It has been observed that ablation of immunoregula-
tory molecules such as transforming growth factor beta (TGF-β)
or heme oxygenase-1 (Hmox1) negatively interferes with implan-
tation (McLennan and Koishi, 2004; Zenclussen et al., 2011).
Thus, a balance between pro- and anti-inflammatory mole-
cules is assumed to support successful implantation. Cells of
the innate immune system present in the uterus are known to
be critical for implantation. For example, uterine natural killer
cells (uNK cells) produce IFN-γ, which contributes to the ini-
tiation of vascular modification and decidual integrity (Ashkar
et al., 2000). Macrophages present in the uterus secrete IL-1,
which is reportedly involved in implantation (Houser et al.,
2011). Ablation of uterine dendritic cells (DC) causes implan-
tation failure due to perturbed angiogenesis (Plaks et al., 2008)
while the absence of uterine mast cells (MCs) leads to defec-
tive implantation and spiral artery remodeling (Woidacki et al.,
2013).
Once implantation is established, a period of maintenance
follows, during which the maternal immune system actively
tolerates the foreign paternal antigens expressed by the fetus
(Tafuri et al., 1995) while being fully active against potential infec-
tions. Maternal CD4+CD25+ regulatory T cells (Tregs) have been
reported to contribute to the maintenance of tolerance during
pregnancy by suppressing maternal alloreactive immune responses
against paternal structures in fetal cells (Zenclussen et al., 2005;
Shima et al., 2010; Rowe et al., 2012; Samstein et al., 2012). It
has been speculated the Tregs also participate at initial stages of
pregnancy, e.g., implantation (Zenclussen et al., 2005; Schumacher
et al., 2007), at which inflammatory processes and innate cell pop-
ulations play an important role. However, conclusive experimental
proof that Tregs are important for implantation was missing.
The present study addresses this question and by using specific
models shows that Foxp3+ Tregs are needed for successful implan-
tation because they prevent the development of a hostile uterine
microenvironment. In their absence, inflammation and fibrosis
occur, both negatively interfering with embryo implantation.
MATERIALS AND METHODS
STUDY APPROVAL
All studies were conducted according to governmental and
institutional regulations (AZ 42502-2-868, Magdeburg; AZ 35-
9185.81/G-98/08, Heidelberg; AO 10/2010, Oeiras).
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MICE AND TREG DEPLETION
Foxp3DTR (Kim et al., 2007) and Foxp3GFP knock-in mice
(Fontenot et al., 2005) were kindly provided by Alexander
Rudensky (Washington, DC, USA) and Jocelyne Demengeot
(Oeiras, Portugal) and bred in our facilities. CCR7−/− mice
were purchased from Jackson Laboratories; C57BL/6 and BALB/c
(intact, vasectomized, and seminal vesicle-deficient) mice from
Charles River, Germany. BAC transgenic Foxp3.LuciDTR-4 mice
(Suffner et al., 2010) were generated and maintained at the DKFZ,
Heidelberg. Mated females were checked daily for vaginal plugs;
its appearance indicates day 0 of pregnancy. Females were mated
and checked daily for vaginal plugs, its appearance indicates day
0.5 of pregnancy. Vaginal lavage was performed with 20µL of
0.9% sodium chloride. Cycle stage was defined after observation
of the cellular components under light microscopy (Axiovert C,
Carl Zeiss, Germany; magnification ×200), and was confirmed
by hematoxylin/Eosin. Treg depletion in Foxp3DTR mice was per-
formed by i.p. application of 15 ng/g body weight diphtheria toxin
(DT) every fourth day. In Foxp3Luci.DTR mice, DT was applied
daily beginning at day −2. Control mice received PBS or DT.
Implantations sites at day 5 of pregnancy were identified after
i.v. injection of 0.5% Chicago Blue dye.
2-PHOTON IN VIVO MICROSCOPY
Imagining of uterine Foxp3GFP cells during the estrus cycle was
performed as follows. Animals were anesthetized by i.p. injection
of ketamine and xylazine, 120 or 16µg/g of mouse weight, respec-
tively, and kept on a heating pad at 37°C. One of the uterine horns
was carefully exposed and 0.1 M caffeine (Sigma-Aldrich, USA)
was applied to decrease uterine contractions. For maternal blood
visualization, animals were intravenously injected with 100µl of
Rhodamine B isothiocyanate-Dextran (RhoB-Dex) 70,000 KDa
(Sigma-Aldrich, Inc., USA) before acquiring images in a multipho-
ton laser scanning microscope (MPLSM). We used a Prairie Ultima
2-photon microscope (Prairie Technologies, Inc.). The microscope
was equipped with a Chameleon Ti:Sapphire laser (Coherent, Inc.,
USA), four top PMTs for simultaneous up to four channel acquisi-
tions and a 20×water immersion objective (Olympus, Inc., USA).
The laser was tuned to 880 nm to allow for concomitant exci-
tation of RhoB-Dex and GFP+-Treg. The wavelength emission
for RhoB-Dex and GFP is 590 and 509 nm, respectively. Sequen-
tial images were acquired for observation of Treg in the uterus.
For analysis of uterine Treg images, we have developed our own
software algorithms based on endogenous tissue markers infor-
mation (e.g., location of blood vessels) from consecutive z-stacks
acquisitions for stabilization of Treg movies. Once the images
were stabilized, we used Imaris software (Bitplane AG, Inc.) for
reconstruction of three-dimensional models in order to determine
distribution in the uterus. For more detail, please see Zenclussen
et al. (2013).
FLOW CYTOMETRY
The following fluorescence-conjugated antibodies were purchased
from BD Biosciences or eBioscience: CD4 (RM-4 or RM4-5),
CD8 (53-6.7), Foxp3 (FJK-16s or NRRF-30), Ki67 (B56), CD44
(IM7), CD62L (Mel-14). Samples were processed as described
(Zenclussen et al., 2005; Woidacki et al., 2013), measured in a
FACSCalibur or FACSCanto II (BD Biosciences) and analyzed with
CellQuest Pro software (BD Biosciences).
HISTOLOGY AND IMMUNOFLUORESCENCE
Analysis of uterine tissue was performed after staining with Hema-
toxylin/Eosin. The slides were dewaxed and left in Hematoxylin
(Fluka Biochemika, Germany) for 1–2 min followed by rinse with
tap water and a further incubation in Eosin (Fluka Biochemika,
Germany) for 1–2 min and finally dehydrated to xylol and cov-
ered. Fibrosis extent was evaluated by Masson’s trichrome and
Picrosirius red stainings. For the first, the dewaxed slides were
left in picrosirius red stain solution (Sigma) for 1 h and rinsed
in 10 dips of water before being dehydrated to xylol and cov-
ered. For Masson’s trichrome staining it was proceed as follows:
after dewaxing, the slides were placed in Bouin’s solution (Sigma)
overnight (ON) for mordating and washed in running tap water
before staining for 5 min in working Weigert’s iron Hematoxylin
solution (Sigma). After washing in running tap water, the samples
were stained in Biebrich Scarlet-acid Fuchsin (Sigma) for 5 min
and rinsed in distilled water. The slides were placed in Phospho-
molybdic/Phosphotungstic acid solution (Sigma) for 10 min and
the solution was discarded and substituted by aniline blue solution
for five more min. Finally, the slides were placed in 1% acetic acid
solution for 3 min and dehydrated to xylol before being covered.
Connective tissue growth factor (CtGF) in uterine tissue was
studied by immunofluorescence. For this, tissue sections were
dewaxed and blocked for 30 min with 3% bovine serum albu-
min (BSA) in PBS at room temperature (RT). The slides were then
washed in PBS and incubated with anti-CTGF primary antibody
(Abcam ab6992) in 2% BSA at a dilution of 1:200 ON at 4°C. After
further washing the slides with PBS they were incubated with Alexa
Fluor 488 goat anti-Rabbit IgG secondary antibody (Abcam) at a
dilution of 1:200 for 45 min at RT. Sections were washed and the
slides were covered with Dapi Vecta Shield mounting medium.
IN VITRO PROLIFERATION
MACS-sorted Treg or effector T cells were stained with carboxy-
fluorescein diacetate succinimidyl ester (CFSE, Molecular Probes,
Leiden, Netherlands), cultured with rmIL-2 (R & D systems) and
treated with freshly prepared seminal vesicle fluid (SVF) from
BALB/c males. Anti-TGF-β1 mAb was kindly provided by Hideo
Yagita (Juntendo University, Tokyo, Japan).
QUANTITATIVE REAL TIME PCR
mRNA was isolated using Trizol® and cDNA synthesis was done
using reverse transcriptase (Invitrogen, Karlsruhe, Germany). Real
time PCR was performed with the help of an iCycler (BIORAD,
Munich, Germany) using SYBR Green (Applied Biosystems, Ger-
many). Initial denaturation was done at 95°C for 5 min followed
by a denaturation step of 40 cycles of 45 s at 95°C. Annealing step
followed at 59°C for 30 s 72°C for 30 s extension. The amount of
cDNA was standardized with the reference gene β-actin. Primers
are available upon request.
STATISTICAL ANALYSIS
Statistical analyses were performed with Prism software (Graph-
Pad). Normality in the distribution of the data was analyzed by
Frontiers in Immunology | Mucosal Immunity June 2013 | Volume 4 | Article 158 | 2
Teles et al. Tregs and implantation
the D’Agostino and Pearson omnibus normality test. Differences
in the percentage of CD4+Foxp3GFP+, CD8+ KI67+, CD44+, and
CD62L+ cells between groups were analyzed by Mann–Whitney-U
test. The in vitro experiments using cells cultured with SVF were
analyzed by two-way ANOVA test. Implantation numbers were
measured at day 5, data are expressed as medians of % of implanted
females and analyzed by Fisher’s exact test. Levels of molecules
measured by qPCR [IL-15, CCR5, CCL19, CXCL3, IL-1b, gp130,
TNF-α, RORγτ, CCL5, CtGF, CXCL9, urokinase-type plasmino-
gen activator (uPA), prostaglandin F receptor (Ptgfr), IL-9, Gal-1,
leukemia inhibitory factor (LIF), p. 53] were analyzed by Mann–
Whitney-U test. Number of animals used for each experiment is
included in the Figure legends.
RESULTS
UTERINE Foxp3+ TREGS ACCUMULATE DURING THE FERTILE PHASE OF
THE CYCLE AT THE ANTIMESOMETRIAL REGION
First, we determined the frequencies of CD4+Foxp3+ Tregs in
samples from Foxp3gfp female animals at each stage of the estrus
cycle (diestrus, proestrus, estrus, metestrus, Figure 1A) by flow
cytometry (Figure 1B). We observed substantial fluctuation in
Treg frequency in the vaginal lavage, with Tregs peaking at the
receptive phase, namely estrus, and decreasing toward metestrus.
In vivo 2-photon microscopy in Foxp3gfp animals impressively
demonstrated a clustering of Tregs in uterine tissue during estrus
(Figure 1C; Movie S1 in Supplementary Material) that was not
observed during the other phases of the estrus cycle, e.g., diestrus
FIGURE 1 |Tregs fluctuate during estrus cycle peaking at estrus,
time point of sexual receptivity. Determination of the estrus cycle in
non-pregnant females according to cell types in vaginal smears (A).
Percentage of CD4+Foxp3GFP+ cells of female Foxp3GFP mice (n=5/cycle
stage) was analyzed in vaginal lavage (B). Data are expressed as single
dot plots with medians and were analyzed by Mann–Whitney-U test
(*P ≤0.05). Snap shots of two-photon microscopy videos of Foxp3GFP
positive cells in uterus performed at different phases of the cycle (C)
estrus phase; (D) diestrus phase; (E) metestrus phase; (F) proestrus
phase.
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[Figure 1D; metestrus (Figure 1E) or proestrus (Figure 1F);
Movies S2–S4 in Supplementary Material]. In agreement with
these findings, previous work has suggested oscillations in uterine
Foxp3 mRNA expression levels during the estrus cycle (Kallikour-
dis and Betz, 2007; Guerin et al., 2011). According to the 2-photon
studies, Tregs seem to accumulate preferentially in the perivascu-
lar space close to small blood vessels at the antimesometrial region
during estrus (Movie S1 in Supplementary Material).
SEMINAL FLUID FOSTERS THE EXPANSION OF UTERINE Foxp3+ TREGS
Next, we paired females with seminal vesicle-deficient, vasec-
tomized, or intact allogeneic males. When compared to virgin
mice, an expansion of Tregs was observed in the uterine drain-
ing lymph nodes from females paired with intact or vasectomized
males, whereas no expansion was found in females mated with
seminal vesicle-deficient males (Figure 2A). Hence, seminal fluid
has a proliferative effect on Tregs in vivo. These results could be
reproduced in vitro with CSFE-labeled CD4+CD25+ Tregs iso-
lated by magnetic cell sorting, which were stimulated to proliferate
by addition of seminal fluid and this was partially inhibited by
addition of anti-TGF β (Figure 2B), whereas conventional T cells
were not affected (Figure 2C). Thus, the accumulation of Tregs at
sexual receptivity is followed by an expansion triggered by seminal
fluid, most likely by TGF-β contained herein.
FIGURE 2 |Tregs expand in vivo and in vitro in presence of seminal
fluid. Percentage of CD4+Foxp3+ cells in the uterine draining lymph
nodes of CBA/J females mated with seminal vesicle-deficient,
vasectomized, or intact BALB/c males was analyzed at day of conception
(day 0.5) and compared to virgin CBA/J females (n=4–7) (A). Statistical
analysis were performed by Mann–Whitney-U test (**P ≤0.01). (B)
Tregs were isolated from non-pregnant CBA/J females by magnetic cell
sorting, stained with CFSE and cultured with seminal vesicle fluid (SVF)
from BALB/c males. TGF-β1 was blocked with anti- TGF-β1 antibody, and
proliferation of Treg determined after 24 h by using FACScan Calibur. Data
are representative of four experiments and expressed as mean with
SEM. Analysis was performed by two-way ANOVA test (**P ≤0.01). (C)
Conventional T effector cells were isolated from non-pregnant CBA/J
females by magnetic cell sorting, stained with CFSE and cultured with
seminal vesicle fluid (SVF) from BALB/c males. TGF-β1 was blocked with
anti- TGF-β1 antibody, and proliferation of Treg determined after 24 h by
using FACScan Calibur. Data are representative of four experiments and
expressed as mean with SEM. Analysis was performed by two-way
ANOVA test and no statistically significant differences were found
among the groups.
Frontiers in Immunology | Mucosal Immunity June 2013 | Volume 4 | Article 158 | 4
Teles et al. Tregs and implantation
DEPLETION OF Foxp3+ TREGS PRIOR TOMATING RESULTED IN UTERINE
INFLAMMATION AND FIBROSIS THAT IMPAIRED IMPLANTATION
As Treg accumulation at receptivity suggested a role for embryo
implantation, we investigated the effect of CD4+Foxp3+ Treg
depletion on implantation by using two distinct strains of
Foxp3.DTR mice, namely Foxp3DTR knock-in mice (Fontenot
et al., 2005), and BAC-transgenic Foxp3.LuciDTR-4 mice (Suffner
et al., 2010). Upon application of DT, at least 90% of CD4+Foxp3+
Tregs were specifically depleted in both strains. Thus, for
Treg depletion Foxp3.DTR mice are superior to the frequently
used anti-CD25 antibodies, which deplete only about 70% of
CD4+Foxp3+ Treg, owing to limited expression of CD25 on
Foxp3+ T cells (Shima et al., 2010). Moreover, Foxp3 represents a
highly selective marker for Tregs, whereas CD25 is also expressed
on a fraction of other leukocytes (Shima et al., 2010). Treg deple-
tion was performed during various time intervals before mating,
namely from day 9 to 5 of pregnancy, and from day 2 to 5. To con-
firm the occurrence of implantations at day 5, Chicago Blue was
utilized (Figure 3A) Treg depletion beginning at day 9 in Foxp3DTR
mice provoked a failure of the embryos to implant, whereas
PBS- and DT-treated control mice displayed normal implanta-
tion (Figures 3B,C). When Foxp3.LuciDTR mice were used, syn-
geneic matings were included in order to elucidate whether the
mechanisms leading to implantation failure were dependent on
potentially present paternal alloantigens (Figure 3C). Treg abla-
tion from day 2 to 5 resulted in severely impaired implantation not
only in biologically relevant allogeneic pregnancies but also in syn-
geneic matings (Figure 3C). We speculated that at this early time
point Tregs may counteract pro-inflammatory events occurring
during implantation. Without Tregs, inflammation may be too
strong and hinder the nidation of the embryo. Indeed, we observed
that Treg depletion resulted in accumulation of CD8+ T cells in the
uterus (Figure 3D) and the presence of activated T cells in lymph
nodes draining the uterus, as indicated by the increased expression
of KI67, CD44, and down-regulation of CD62L in CD4+Foxp3−
effector cells (Figures 3E–G). Additionally, the uterine tissue was
inflamed and thickened after DT treatment. mRNA expression of
the inflammatory mediators IL-15, CCR5, CCL19, and CXCL3,
all inflammatory was upregulated (Figures 4A–D). Levels of IL-
1β, gp130, TNF-α, ROR-gamma-t, or CCL5 were not significantly
modified (Figures 5A–E). We also observed the appearance of
fibrosis in the uterus of mice depleted of Treg as indicated by ele-
vated levels of CtGF and CXCL9 mRNA (Figures 6A,B), important
regulators of fibrosis (Gressner and Gressner, 2008; Zeremski et al.,
2011). Fibrosis was further confirmed histologically in mice devoid
of Tregs by means of Hematoxylin-Eosin (Figure 6Cii), Picrosirius
(Figure 6Civ), and the Masson’s trichrome staining (Figure 6Cv)
as well as by means of CtGF immunofluorescence (Figure 6Cviii)
as compared to DT-treated control mice (Figures 6Ci,iii,v,vii).
The levels of uPA, known to positively influence tissue remodel-
ing and whose absence leads to infertility (Carmeliet et al., 1994),
were downregulated and almost undetectable in the absence of
Tregs (Figure 6D). It is of interest that Ptgfr was also upregulated
(Figure 6E) as prostaglandin is routinely given to provoke ther-
apeutic abortions (Wagner et al., 2011). No changes were found
in the levels of the immunosuppressive factors IL-9 and Gal-1
(Figures 7A,B). LIF and p53, known to define fertility (Hu et al.,
2007), were also not modified after Treg depletion (Figures 7C,D).
Inflammation and fibrosis were only investigated in syngeneic
matings in order to investigate the effects of Treg depletion inde-
pendent of allogenicity. Together, the data indicate that depletion
of Tregs prior to mating leads to a hostile uterine environment that
is characterized by the occurrence of inflammation and fibrosis,
thereby interfering with implantation.
CCR7 MEDIATED THE HOMING OF TREG TO THE UTERUS AND ITS
GENETIC ABLATION IMPAIRED IMPLANTATION
The chemokine receptor CCR7 has been identified as a hom-
ing receptor on Tregs required for migration to lymph nodes
and spleen (Worbs and Förster, 2007). In order to explore a
role for CCR7 in Treg homing into the uterus and for embryo
implantation, we employed CCR7-deficient mice. The number
of CD4+Foxp3+ Treg in the uterus was drastically reduced in
CCR7−/− mice (Table 1), whereas the frequency of conventional
CD4+Foxp3− T cells was only partially reduced (data not shown).
Consistent with the absence of uterine Treg, CCR7 deficiency
resulted in implantation failure (Table 1). Supporting our find-
ings on the importance of CCR7 on Treg for implantation, Guerin
et al. (2011) reported the presence of CCL19, the ligand for CCR7,
in glandular and luminal uterine epithelial cells, however a role
for this chemokine for the recruitment of Treg into the uterus was
not investigated. We show here that CCR7 mediates the homing
of Treg to the uterus and that its absence hampers implantation.
DISCUSSION
The presence of Foxp3+ Tregs in uterus during early pregnancy
has already been reported (Schumacher et al., 2007; Thuere et al.,
2007). Here, by employing flow cytometry, we confirm that these
cells are present in the uterus in the non-pregnant state and that
they further fluctuate during the different phases of the estrous
cycle. It seems that this fluctuation occurs in response to hor-
mones, as has been proposed after observing variations in the
Foxp3 mRNA levels (Kallikourdis and Betz, 2007; Guerin et al.,
2011). In vivo 2-photon microscopy in Foxp3gfp animals impres-
sively confirmed oscillations in the frequency of Treg in the uterus
and further revealed a clustering of Tregs in uterine tissue during
the receptive phase of the cycle, the estrus. This may be interpreted
as an accumulation of these cells at the future implantation niches
and preparation of the uterus for implantation.
We further observed that Foxp3+ Tregs expanded immediately
after copulation at day 0 of pregnancy. The expansion occurred
after mating females with intact or vasectomized males but not
after mating with males lacking seminal vesicles, suggesting that
components of the seminal fluid are active in expanding Tregs
which is in accordance with other reports (Robertson et al., 2009;
Guerin et al., 2011). Treg expansion by seminal fluid could be con-
firmed by in vitro experiments that further indicated TGF-β as
a possible modulator of Treg expansion. Hence, Treg presence at
the moment of pairing and their further expansion by paternal
components implies a role for embryo implantation.
To investigate the potential role of CD4+Foxp3+ Tregs we
employed two distinct strains of Foxp3.DTR mice for Treg
depletion, namely Foxp3DTR knock-in mice and BAC-transgenic
Foxp3.LuciDTR-4 mice. We observed that depletion of Tregs
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FIGURE 3 | Embryo implantation is impaired afterTreg depletion. Foxp3+
Treg were depleted in Foxp3DTR mice by application of DT every fourth day,
starting 9 days before mating (day 9) with BALB/c males. Control groups
received PBS. (A) shows a representative picture of a uterus stained at day 5
post conception with Chicago Blue dye application. The arrow indicates a
representative implantation site. The percentage of females presenting
implantations was analyzed on day 5 after mating [(B), n= 5–12]. Foxp3+ Treg
were depleted in Foxp3.LuciDTR-4 mice by daily application of DT, starting on
day 2 with allogeneic (CBAJ) or syngeneic (C57/BL6) males. Control groups
were wt C57/BL6 females treated with DT. Implantation numbers were
measured at day 5 [(C), n=15–21]. For (B,C), data are expressed as medians
of % of implanted females and analyzed by Fisher’s exact test (#P <0.1,
*P <0.05). Not all plugged animals became pregnant. In samples from
animals shown in Figure 3B, the percentage of CD8+ cells was analyzed in
the uterus by flow cytometry (D), and the percentage of KI67+, CD44+, and
CD62L+ (E–G) determined in uterine draining lymph nodes (n=5/group).
Data are expressed as medians and were analyzed by Mann–Whitney-U test
(*P <0.05; **P <0.01).
prior to mating resulted in a dramatic impairment of implan-
tation. In line with this, it was recently reported that dimin-
ished endometrial Foxp3 mRNA was associated with infertility
in women (Jasper et al., 2006). We speculated that at this early
time point Tregs may counteract pro-inflammatory events occur-
ring during implantation and facilitate a uterine environment that
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FIGURE 4 | Depletion of Tregs creates an inflammatory uterine milieu. In
samples from Foxp3.LuciDTR-4 or wild type animals treated with DT by daily
application starting on day 2 and further mated syngeneically, inflammation
markers were measured (n=4–6/group) in uterine tissue by qPCR. Levels of
IL-15 (A), CCR5 (B), CCL19 (C), and CXCL3 (D) were significantly elevated in
mice depleted of Tregs as compared to DT-treated controls. Data are
expressed as single dots with medians and were analyzed by
Mann–Whitney-U test (#P <0.1, P <0.05; **P <0.01).
supports implantation. Without Tregs, inflammation may be too
strong and may favor a hostile uterine microenvironment that
would hinder nidation of the embryo. Indeed, we observed a
strong upregulation of the pro-inflammatory mediators IL-15,
CCR5 CCL19 and CXCL3. We also found augmented levels of
CD8+ cells and activated CD4+ cells in uterus. These findings are
supported by studies showing that Treg depletion in Foxp3.DTR
mice leads to T cell activation and pro-inflammatory modulation
of the microenvironment of sites where Tregs accumulate, such as
tumors (Li et al., 2010). Besides inflammation and accumulation
of effector cells, we observed swollen uteruses that were devoid of
implantations. The development of uterine fibrosis was indicated
by the upregulation of CtGF and CXCL9. uPA, a positive regulator
of tissue remodeling in the uterus was almost undetectable in the
absence of Treg, which is in line with impaired infertility of uPA
deficient animals (Carmeliet et al., 1994). Our data reveals that
the lack of Tregs results in uterine conditions that are hostile for
the embryo to implant. The levels of the known fertility factors
LIF and p53 (Hu et al., 2007) were not modified in the absence
of Treg.
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FIGURE 5 | Depletion of Tregs does not provoke changes in the levels of
IL-1b, gp130,TNF-α, ROR-γτ, or CCL5. In samples from Foxp3.LuciDTR-4 or
wild type animals treated with DT by daily application starting on day 2 and
further mated allogeneically, inflammation markers were measured
(n= 4–6/group) in uterine tissue by qPCR. Levels of IL-1b (A), gp130 (B), TNF-α
(C), RORγτ (D), and CCL5 (E) mRNA were comparable in mice depleted of
Tregs and DT-treated controls. Data are expressed as single dot plots with
medians and were analyzed by Mann–Whitney-U test. No statistically
significant differences were observed between both groups in any of the
molecules.
We conclude that Treg are pivotal for implantation as they
control the uterine microenvironment needed for the blasto-
cyst to attach and grow in the uterus. Many of the effects
seen here after Treg depletion are reminiscent of clinical para-
meters associated with infertility. Pathologies like endometri-
tis, endometriosis, inflammatory pelvic diseases, and fallopian
tube blockage associated with inflammatory processes cause
the metamorphosis of reproductive tract tissues and vaginal
fluid and are often a cause of infertility by hindering nida-
tion (Shah et al., 2005; He et al., 2010; Braundmeier et al.,
2012). Likewise, it is known that, e.g., pelvic inflammation, uter-
ine swelling, and intraluminal occluding fibrosis of the oviduct
after infections with Chlamydia sp. are associated with infer-
tility (Weiss et al., 2009; Wiesenfeld et al., 2012). Thus, it
seems that the specific depletion of Treg mimics alterations
induced by pathogens that lead to infertility, specifically an
inflammatory milieu and fibrosis, thereby hindering successful
implantation.
The targets for regulation by uterine Tregs are not clear,
but as T cell-deficient mice such as RAG mutant mice lack
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FIGURE 6 |Treg depletion leads to uterine fibrosis. In samples from
Foxp3.LuciDTR-4 or wild type animals treated with DT by daily application
starting on day 2 and further mated syngeneically, fibrosis markers were
measured (n=4–6/group) in uterine tissue by qPCR. Levels of CtGF (A) and
CXCL9 (B) were significantly elevated in mice depleted of Tregs as compared
to DT-treated controls. Data are expressed as single dots with medians and
were analyzed by Mann–Whitney-U test (#P <0.1, **P < 0.01). Additionally,
staining with Hematoxylin/Eosin revealed fibrosis areas with disorganized
collagen fibers in animals without Tregs compared to wild type controls (C ii
vs. i). Pricosirius red staining revealed a higher amount of green/blue-stained
thin collagen fibers that confirms fibrosis in mice devoid of Tregs vs. controls
(C iv vs. iii). Further, Masson’s staining manifested larger areas of collagen
fibers in blue/violet in DT-treated Foxp3.Luci.DTR animals compared to
DT-treated controls (C vi vs. v). Finally in (C vii, viii), immunofluorescence
staining for CtGF confirmed accumulation of CtGF positive cells in mice
depleted in Tregs as compared to the controls. All pictures were taken with a
10× objective. Analysis of uPA mRNA revealed that animals depleted in Tregs
presented very low, almost undetectable levels of this molecule as compared
to DT-treated controls (D). Treg depletion further provoked an augmentation of
prostaglandin 1A mRNA (E).
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FIGURE 7 |Treg depletion does not provoke changes in IL-9, Gal-1, LIF,
or p53. In samples from Foxp3.LuciDTR-4 or wild type animals treated with
DT by daily application starting on day 2 and further mated allogeneically,
inflammation markers were measured (n=4–6/group) in uterine tissue by
qPCR. Levels of IL-9 (A), Gal-1 (B), LIF (C), and p53 (D) mRNA were
comparable in mice depleted of Tregs and DT-treated controls. Data are
expressed as single dot plots with medians and were analyzed by
Mann–Whitney-U test. No statistically significant differences were
observed between both groups in any of the molecules.
both Tregs and effector T cells, but present normal implanta-
tion rates, it seems reasonable to assume that effector T cells
are major targets and that uterine Tregs serve to control exces-
sive production of inflammatory cytokines. We also demonstrated
that homing of Tregs to the uterus depends on CCR7 and that
CCR7 deficiency resulted in implantation failure. In support
of this finding, Guerin et al. (2011) described the presence of
CCL19, the ligand for CCR7, in glandular and luminal uterine
epithelial cells.
Table 1 | Consequences of CCR7 deficiency in number of uterineTregs
and implantation rate.
% of uterine Foxp3+
cells within CD4 cells
Implantation rate
Wild type controls (n=5) 11.97 (4.48–21.1) 100%
CCR7−/− animals (n=5) 0 (0–0.01) 55%
Statistical significance <0.05 <0.05
In another study it was reported that Treg depletion with
anti-CD25 antibody at day 2.5 post conception would hinder
implantation only in allogeneic but not syngeneic mating com-
binations (Shima et al., 2010). At first sight this appears to be at
disagreement with our findings that Treg depletion in Foxp3.DTR
mice causes implantation failure also in syngeneic matings. How-
ever, in view of the fact that Foxp3.DTR allow more efficient and
more specific depletion of Tregs the above authors themselves have
suggested the use of Foxp3.DTR mice for respective studies, as has
been done here (Shima et al., 2010).
Once pregnancy is established, the embryo expressing pater-
nal antigens needs to be protected against the maternal immune
system. In several reports Tregs have been shown to be impor-
tant for this process (Zenclussen et al., 2005; Schumacher et al.,
2007; Samstein et al., 2012). Using the same Foxp3.DTR knock-in
mice employed here, Samstein et al. (2012) have shown that the de
novo conversion of Treg in the periphery contributes to embryo
protection. However, as only 10% of all embryos are rejected in
the absence of Foxp3+ Tregs their protective role for maintaining
the integrity of the fetus appears to be limited as compared to the
strong effect of Treg on implantation observed here. Additional
and multiple mechanisms must exist to ensure maternal toler-
ance toward the fetus. Several distinct tolerance mechanisms have
been reported, such as awareness of maternal T cells for paternal
alloantigens and acquisition of a transient state of tolerance during
pregnancy (Tafuri et al., 1995), ignorance of fetus-specific T cells,
epigenetic silencing in decidual tissue of chemokines that attract
T cells (Nancy et al., 2012), and others.
In view of the importance of pregnancy for survival of a
species; its first phase, namely embryo implantation, must be
tightly controlled. Our data reveal the importance of Treg for this
process, likely by suppressing excessive inflammation in the uterine
microenvironment. The results are relevant for human pregnan-
cies, especially when designing protocols for improving fertility.
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Movie S1 | Estrus: 3D reconstruction of live 2-photon-microscopy of uterus
from a representative Foxp3gfp animal during the estrus phase oft he estrus
cycle. The green cells are Tregs clustered at the mesometrial region. Animals
were anesthetized by i.p. injection of ketamine and xylazine, 120 or 16µg/g of
mouse weight, respectively, and kept on a heating pad at 37°C. One of the
uterine horns was carefully exposed and 0.1 M caffeine (Sigma-Aldrich, USA)
was applied to decrease uterine contractions. For maternal blood visualization,
animals were intravenously injected with 100µl of Rhodamine B isothiocyanate-
Dextran (RhoB-Dex) 70,000 KDa (Sigma-Aldrich, Inc., USA) before acquiring
images in a multiphoton laser scanning microscope (MPLSM). We used a Prairie
Ultima 2-photon microscope (Prairie Technologies, Inc.). The microscope was
equipped with a Chameleon Ti:Sapphire laser (Coherent, Inc., USA), four top
PMTs for simultaneous up to four channel acquisitions and a 20× water immer
sion objective (Olympus, Inc., USA). The laser was tuned to 880 nm to allow for
concomitant excitation of RhoB-Dex and GFP+-Treg. The wavelength emission
for RhoB-Dex and GFP is 590 and 509 nm, respectively. Sequential images were
acquired for observation of Treg in the uterus. For analysis of uterine Treg
images, we have developed our own software algorithms based on endogenous
tissue markers information (e.g., location of blood vessels) from consecutive
z-stacks acquisitions for stabilization of Treg movies. Once the images were
stabilized, we used Imaris software (Bitplane AG, Inc.) for reconstruction of
three-dimensional models in order to determine distribution in the uterus.
Movie S2 | Diestrus: depicts a 3D reconstruction of representative live
2-photon-microscopy of uterus from a Foxp3gfp animal at diestrus. Green
Tregs are scarce. Animals were anesthetized by i.p. injection of ketamine and
xylazine, 120 or 16µg/g of mouse weight, respectively, and kept on a heating
pad at 37°C. One of the uterine horns was carefully exposed and 0.1 M caffeine
(Sigma-Aldrich, USA) was applied to decrease uterine contractions. For maternal
blood visualization, animals were intravenously injected with 100µl of
Rhodamine B isothiocyanate-Dextran (RhoB-Dex) 70,000 KDa (Sigma-Aldrich,
Inc., USA) before acquiring images in a multiphoton laser scanning microscope
(MPLSM). We used a Prairie Ultima 2-photon microscope (Prairie Technologies,
Inc.). The microscope was equipped with a Chameleon Ti:Sapphire laser
(Coherent, Inc., USA), four top PMTs for simultaneous up to four channel
acquisitions and a 20× water immersion objective (Olympus, Inc., USA). The
laser was tuned to 880 nm to allow for concomitant excitation of RhoB-Dex and
GFP+-Treg. The wavelength emission for RhoB-Dex and GFP is 590 and 509 nm,
respectively. Sequential images were acquired for observation of Treg in the
uterus. For analysis of uterine Treg images, we have developed our own
software algorithms based on endogenous tissue markers information (e.g.,
location of blood vessels) from consecutive z-stacks acquisitions for stabilization
of Treg movies. Once the images were stabilized, we used Imaris software
(Bitplane AG, Inc.) for reconstruction of three-dimensional models in order to
determine distribution in the uterus.
Movie S3 | Metestrus: shows a video from a 3D reconstruction of live
2-photon microscopy showing almost undetectable greenTregs within the
uterus. Animals were anesthetized by i.p. injection of ketamine and xylazine,
120 or 16µg/g of mouse weight, respectively, and kept on a heating pad at
37°C. One of the uterine horns was carefully exposed and 0.1 M caffeine
(Sigma-Aldrich, USA) was applied to decrease uterine contractions. For maternal
blood visualization, animals were intravenously injected with 100µl of
Rhodamine B isothiocyanate-Dextran (RhoB-Dex) 70,000 KDa (Sigma-Aldrich,
Inc., USA) before acquiring images in a multiphoton laser scanning microscope
(MPLSM). We used a Prairie Ultima 2-photon microscope (Prairie Technologies,
Inc.). The microscope was equipped with a Chameleon Ti:Sapphire laser
(Coherent, Inc., USA), four top PMTs for simultaneous up to four channel
acquisitions and a 20× water immersion objective (Olympus, Inc., USA). The
laser was tuned to 880 nm to allow for concomitant excitation of RhoB-Dex and
GFP+-Treg. The wavelength emission for RhoB-Dex and GFP is 590 and 509 nm,
respectively. Sequential images were acquired for observation of Treg in the
uterus. For analysis of uterine Treg images, we have developed our own
software algorithms based on endogenous tissue markers information (e.g.,
location of blood vessels) from consecutive z-stacks acquisitions for stabilization
of Treg movies. Once the images were stabilized, we used Imaris software
(Bitplane AG, Inc.) for reconstruction of three-dimensional models in order to
determine distribution in the uterus.
Movie S4 | Proestrus: distribution of green Foxp3gfp+ cells (Tregs) inside the
uterus during proestrus. Animals were anesthetized by i.p. injection of
ketamine and xylazine, 120 or 16µg/g of mouse weight, respectively, and kept
on a heating pad at 37°C. One of the uterine horns was carefully exposed and
0.1 M caffeine (Sigma-Aldrich, USA) was applied to decrease uterine
contractions. For maternal blood visualization, animals were intravenously
injected with 100µl of Rhodamine B isothiocyanate-Dextran (RhoB-Dex)
70,000 KDa (Sigma-Aldrich, Inc., USA) before acquiring images in a multiphoton
laser scanning microscope (MPLSM). We used a Prairie Ultima 2-photon
microscope (Prairie Technologies, Inc.). The microscope was equipped with a
Chameleon Ti:Sapphire laser (Coherent, Inc., USA), four top PMTs for
simultaneous up to four channel acquisitions and a 20× water immersion
objective (Olympus, Inc., USA). The laser was tuned to 880 nm to allow for
concomitant excitation of RhoB-Dex and GFP+-Treg. The wavelength emission
for RhoB-Dex and GFP is 590 and 509 nm, respectively. Sequential images were
acquired for observation of Treg in the uterus. For analysis of uterine Treg
images, we have developed our own software algorithms based on endogenous
tissue markers information (e.g., location of blood vessels) from consecutive
z-stacks acquisitions for stabilization of Treg movies. Once the images were
stabilized, we used Imaris software (Bitplane AG, Inc.) for reconstruction of
three-dimensional models in order to determine distribution in the uterus.
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